BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32226309)

  • 1. USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2.
    Dou N; Hu Q; Li L; Wu Q; Li Y; Gao Y
    Int J Biol Sci; 2020; 16(9):1648-1657. PubMed ID: 32226309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers.
    Akhavantabasi S; Akman HB; Sapmaz A; Keller J; Petty EM; Erson AE
    Mamm Genome; 2010 Aug; 21(7-8):388-97. PubMed ID: 20549504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer.
    Hu W; Wei H; Li K; Li P; Lin J; Feng R
    Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28597490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer.
    Fu Y; Ma G; Liu G; Li B; Li H; Hao X; Liu L
    Cancer Med; 2018 Nov; 7(11):5577-5588. PubMed ID: 30296012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan-mediated motility receptor confers resistance to chemotherapy
    Zhang H; Ren L; Ding Y; Li F; Chen X; Ouyang Y; Zhang Y; Zhang D
    FASEB J; 2019 May; 33(5):6365-6377. PubMed ID: 30802150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive feedback loop of IL-1β/Akt/RARα/Akt signaling mediates oncogenic property of RARα in gastric carcinoma.
    Ren HY; Liu F; Huang GL; Liu Y; Shen JX; Zhou P; Liu WM; Shen DY
    Oncotarget; 2017 Jan; 8(4):6718-6729. PubMed ID: 28035062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ubiquitin-specific protease 32 as an oncogene in glioblastoma and the underlying mechanisms.
    Chen S; Chen X; Li Z; Mao J; Jiang W; Zhu Z; Li Y; Jiang Z; Zhao W; Tan G; Wang Z
    Sci Rep; 2022 Apr; 12(1):6445. PubMed ID: 35440702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma.
    Xiu M; Bao W; Wang J; Chen J; Li Y; Hai Y
    BMC Cancer; 2023 Nov; 23(1):1105. PubMed ID: 37957631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1.
    Nakae A; Kodama M; Okamoto T; Tokunaga M; Shimura H; Hashimoto K; Sawada K; Kodama T; Copeland NG; Jenkins NA; Kimura T
    Biochem Biophys Res Commun; 2021 May; 552():120-127. PubMed ID: 33744759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.
    Chandrasekaran AP; Kaushal K; Park CH; Kim KS; Ramakrishna S
    Theranostics; 2021; 11(20):9752-9771. PubMed ID: 34815782
    [No Abstract]   [Full Text] [Related]  

  • 11. PIEZO1 functions as a potential oncogene by promoting cell proliferation and migration in gastric carcinogenesis.
    Zhang J; Zhou Y; Huang T; Wu F; Liu L; Kwan JSH; Cheng ASL; Yu J; To KF; Kang W
    Mol Carcinog; 2018 Sep; 57(9):1144-1155. PubMed ID: 29683214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircFOXO3 functions as a molecular sponge for miR-143-3p to promote the progression of gastric carcinoma via upregulating USP44.
    Xiang T; Jiang HS; Zhang BT; Liu G
    Gene; 2020 Aug; 753():144798. PubMed ID: 32445925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer.
    Wu X; Liu M; Zhu H; Wang J; Dai W; Li J; Zhu D; Tang W; Xiao Y; Lin J; Zhang W; Sun Y; Zhang Y; Chen Y; Li G; Li A; Xiang L; Liu S; Wang J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):277. PubMed ID: 31234902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
    Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
    EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
    Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
    Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophilin A Enhances Cell Proliferation and Xenografted Tumor Growth of Early Gastric Cancer.
    Feng W; Xin Y; Xiao Y; Li W; Sun D
    Dig Dis Sci; 2015 Sep; 60(9):2700-11. PubMed ID: 26008617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0017639 expression promotes gastric cancer proliferation and metastasis by sponging miR-224-5p and upregulating USP3.
    Li B; Jin M; Cao F; Li J; Wu J; Xu L; Liu X; Shi Y; Chen W
    Gene; 2020 Aug; 750():144753. PubMed ID: 32376451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation.
    Yu S; Li L; Wu Q; Dou N; Li Y; Gao Y
    Int J Oncol; 2018 Jun; 52(6):2011-2020. PubMed ID: 29568966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling.
    Liu H; Liu N; Zhao Y; Zhu X; Wang C; Liu Q; Gao C; Zhao X; Li J
    Aging (Albany NY); 2019 Nov; 11(21):9643-9660. PubMed ID: 31689236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBXIP promotes gastric cancer
    Yang Z; Jiang X; Li D; Jiang X
    Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.